SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-21-000221
Filing Date
2021-11-08
Accepted
2021-11-08 08:00:53
Documents
77
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sesn-20210930.htm   iXBRL 10-Q 1488251
2 EX-31.1 sesn-09302021x10qex311.htm EX-31.1 11751
3 EX-31.2 sesn-09302021x10qex312.htm EX-31.2 11676
4 EX-32.1 sesn-09302021x10qex321.htm EX-32.1 6236
5 EX-32.2 sesn-09302021x10qex322.htm EX-32.2 6200
  Complete submission text file 0001485003-21-000221.txt   6844852

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20210930.xsd EX-101.SCH 52332
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sesn-20210930_cal.xml EX-101.CAL 53931
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sesn-20210930_def.xml EX-101.DEF 216582
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20210930_lab.xml EX-101.LAB 603524
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20210930_pre.xml EX-101.PRE 387095
11 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20210930_htm.xml XML 1071966
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 211386565
SIC: 2834 Pharmaceutical Preparations